These reports are aggregated from clinical isolates submitted to the UCSF Clinical Microbiology Laboratory from adult patients at the UCSF Parnassus, Mission Bay, and Mt. Zion locations and are meant to guide clinicians in selecting empiric therapy. Patient characteristics must be incorporated in determining risks and therapy should be modified based on susceptibility testing results when available. Breakpoints for susceptibility are via CLSI guidelines. This page was last updated 6/3/24.
Current Susceptibility Data
Inpatient and Intensive Care Unit
Gram-Negative Organisms
- Report by Organism and Drug
- Incidence-Weighted/Location Specific Gram-negative Coverage by Drug - Parnassus (PDF)
Gram-Positive Organisms
Outpatient
Historical Antibiograms
Standard Adult Antibiograms
- Reporting of susceptibility to commonly used antimicrobials among inpatients and outpatients, broken down by organism
Standard Adult Antibiogram 2023 (PDF)
Standard Adult Antibiogram 2022 (PDF)
Standard Adult Antibiogram 2021 (PDF)
Standard Adult Antibiogram 2020 (PDF)
Standard Adult Antibiogram 2019 (PDF)
Incidence-Weighted Location-specific Gram-negative Combination Antibiograms
- Susceptibility of aggregated Gram-negative organisms to single agents and to combinations, stratified by location at time of culture (ED, floor, ICU)
Incidence-Weighted Location-specific Gram-negative Combination Antibiogram 2017-2020